ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Final NHS green light for Amgen’s Kyprolis
pharmatimes
July 21, 2017Patients living with multiple myeloma across England and Wales should now get ‘routine’ access to Amgen’s Kyprolis on the NHS within three months following a final green light from the National Institute for Health and Care Excellence.
Pharma Sources Insight January 2025
